Mapping CircRNA-miRNA-mRNA Regulatory Axis Identifies Hsa_circ_0080942 and Hsa_circ_0080135 As a Potential Theranostic Agents for SARS-CoV-2 Infection
Overview
Authors
Affiliations
Non-coding RNAs (ncRNAs) can control the flux of genetic information; affect RNA stability and play crucial roles in mediating epigenetic modifications. A number of studies have highlighted the potential roles of both virus-encoded and host-encoded ncRNAs in viral infections, transmission and therapeutics. However, the role of an emerging type of non-coding transcript, circular RNA (circRNA) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has not been fully elucidated so far. Moreover, the potential pathogenic role of circRNA-miRNA-mRNA regulatory axis has not been fully explored as yet. The current study aimed to holistically map the regulatory networks driven by SARS-CoV-2 related circRNAs, miRNAs and mRNAs to uncover plausible interactions and interplay amongst them in order to explore possible therapeutic options in SARS-CoV-2 infection. Patient datasets were analyzed systematically in a unified approach to explore circRNA, miRNA, and mRNA expression profiles. CircRNA-miRNA-mRNA network was constructed based on cytokine storm related circRNAs forming a total of 165 circRNA-miRNA-mRNA pairs. This study implies the potential regulatory role of the obtained circRNA-miRNA-mRNA network and proposes that two differentially expressed circRNAs hsa_circ_0080942 and hsa_circ_0080135 might serve as a potential theranostic agents for SARS-CoV-2 infection. Collectively, the results shed light on the functional role of circRNAs as ceRNAs to sponge miRNA and regulate mRNA expression during SARS-CoV-2 infection.
Wu J, Li L, Xu W, Xia X, Wu Y Funct Integr Genomics. 2025; 25(1):4.
PMID: 39745517 DOI: 10.1007/s10142-024-01509-6.
Ferroptosis and circular RNAs: new horizons in cancer therapy.
Bhat A, Kukreti N, Afzal M, Goyal A, Thapa R, Ali H EXCLI J. 2024; 23:570-599.
PMID: 38887390 PMC: 11180955. DOI: 10.17179/excli2024-7005.
CircRNA: a rising therapeutic strategy for lung injury induced by pulmonary toxicants.
Liao C, He Z, Yu R, Yu Y, Liu X, Kong D Arch Toxicol. 2024; 98(5):1297-1310.
PMID: 38498160 DOI: 10.1007/s00204-024-03706-5.
Liu X, Xiong W, Ye M, Lu T, Yuan K, Chang S Signal Transduct Target Ther. 2023; 8(1):441.
PMID: 38057315 PMC: 10700414. DOI: 10.1038/s41392-023-01669-0.
Di Salvatore V, Crispino E, Maleki A, Nicotra G, Russo G, Pappalardo F Comput Struct Biotechnol J. 2023; 21:3339-3354.
PMID: 37347079 PMC: 10259169. DOI: 10.1016/j.csbj.2023.06.007.